Beta Drugs Limited — Call Transcript 2025

Nov 3, 2025

==> picture [519 x 110] intentionally omitted <==

BDL/PKL/SEC/2025 3[rd] November, 2025

National Stock Exchange of India Ltd. Exchange Plaza, 5th Floor Plot no. C/l, G Block Bandra-Kurla Complex, Bandra (E) Mumbai — 400 051.

SYMBOL-BETA

Sub.: Earnings conference call to discuss Operational and Financial performance H1 FY26.

Dear Sir,

Pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Management of our Company will be hosting an Earnings conference call to discuss Operational and Financial performance H1 FY26 on Friday, 7[th] November, 2025 at 2:00 P.M. (IST).

We are enclosing herewith the invitation to the conference call for reference.

Thanking You Your’s faithfully For Beta Drugs Ltd.

==> picture [121 x 48] intentionally omitted <==

Rajni Brar Company Secretary

==> picture [489 x 79] intentionally omitted <==

==> picture [100 x 100] intentionally omitted <==

==> picture [197 x 74] intentionally omitted <==

Conference Call Invitation H1 FY26 Earnings Call

==> picture [695 x 29] intentionally omitted <==

----- Start of picture text -----

PhillipCapital (India) Private Limited cordially invites you to participate in
----- End of picture text -----

Beta Drugs Ltd. H1 FY26 Earnings conference call t o discuss operational and financial performance

Speakers

Mr. Rahul Batra – Chairman & Managing Director Mr. Nipun Arora – Chief Financial Officer Mr. Ashutosh Shukla – Director (Sales & Marketing)

NSE-SME: BETA | INE351Y01019 Bloomberg: BETADR IN

Call Leader

Mr. Apurva Shah / Mr. Srisurya Kalagarla

Friday – 7[th] November, 2025 @ 02:00 PM IST 04:30 PM Singapore & HK / 08:30 AM UK

Pre-register to avoid wait time, join with DiamondPass Click Here to register

Dial-In-Numbers

Primary Number: +91 22 6280 1143/+91 22 7115 8044 The numbers listed above is universally accessible from all networks and all countries. Toll Free Number: USA: 18667462133 / UK: 08081011573 / Singapore: 8001012045 / Hong Kong: 800964448

• #PhillipCapital (India) Private Limited remains committed to adhere to all regulatory guidelines and follow the best governance and transparency practices. Therefore:

• The proceedings of this call will be recorded.

• The list and full details of participants on the call will be shared by us with the corporate. Participants are expected to provide true and legitimate details.

• All necessary disclosures on Stock Exchanges (including call invite intimation, recording details & call transcript) is expected to be complied by the respective corporate.